Why Argus Thinks Now Is the Time to Buy Vertex
Argus has been waiting for a better valuation to upgrade Vertex Pharmaceuticals, and the recent weakness in the stock price has given the firm the opportunity.
Argus has been waiting for a better valuation to upgrade Vertex Pharmaceuticals, and the recent weakness in the stock price has given the firm the opportunity.
The Dallas Fed rounded out a full run of negative indications in the September factory sector with the general activity index remaining in deeply negative ground.
Merrill Lynch added CSX to its US 1 list as the firm now believes that CSX shares are attractively valued.
Whole Foods Market shook up the markets Monday morning when it announced that it would be cutting 1,500 jobs within the next two months.
Credit Suisse and Wells Fargo have weighed in on BlackBerry in the wake of its underwhelming earnings report.
Despite its underwhelming 2015 thus far, Credit Suisse has upgraded Citigroup, as the valuation now appears to more adequately discount the firms concerns.
Verastem has announced that it has stopped enrollment in its Phase 2 study of VS-6063 for patients with mesothelioma.
24/7 Wall St. has put together a preview of Costco, Micron Technology and some of the companies reporting their quarterly results this week.
24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a single tweet did to them last week.
ThinkstockPetco Holdings, Inc. filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. There were no terms given in the filing. The company has yet to…
BlackBerry reported disappointing fiscal second-quarter financial results before the markets opened Friday.
Pier 1 Imports reported disappointing fiscal second-quarter financial results after the markets closed on Thursday.
1st Century Bancshares has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
The September 15 short interest data have been compared with the previous figures, and short interest for the selected big oil stocks increased almost across the board.
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
The short interest data have come out for the September 15 settlement date. Short sellers appear to have mixed feelings on these semiconductor stocks.
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
ThinkstockBed Bath & Beyond Inc. (NASDAQ: BBBY) reported its fiscal second quarter financial results on Thursday after the markets closed. The company had $1.21 in earnings per share (EPS) on $3.00 billion in revenue…
Wikimedia CommonsCaterpillar Inc. (NYSE: CAT) plans a reorganization of its divisions across the company in an effort to improve efficiency and reduce complexity. Specifically, the company announced Thursday morning, a reorganization in its dealer…
Wikimedia CommonsBlackBerry Limited (NASDAQ: BBRY) is scheduled to report its most recent quarterly results before the markets open on Friday. The consensus estimates call for a net loss of $0.09 per share on $610.99…